Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Robert Stephens, CFA, discusses the outlook for AstraZeneca and Smith & Nephew.
Financial markets are on a roller coaster this year. On the one hand, we have very unfavourable macro and geopolitical conditions. But, on the other hand, the ‘bulls keep buying the dips’.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
The need to think more broadly has seen an increasing number of investors move away from traditional investments and seek alternative “hard” assets, such as fine wine, whose underlying intrinsic value tends to drive greater resilience during turbulent and inflationary times.
Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small-cap equities.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
It has been a brutal few months for many growth-oriented trusts including in the UK smaller companies sector, with the sell-off giving longer term investors the chance to pick up a few bargains.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.